CLINICAL_TRIALS
trial_result
· 2022-02-04
Clinical Trial Update: Long Term Daily Use of JARDIANCE® Tablets in Japanese Patients With Type 2 Diabetes Mellitus
Summary
Long-term daily use study of JARDIANCE tablets in Japanese adults with Type 2 diabetes completed; results posted in 2022.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED | Results posted: 2022-02-04